Medication Description: Lipostabil
LIPOSTABIL (Lipostabil) *.
A complex preparation, produced in capsules (forte), containing unsaturated fatty acids (linoleic, linolenic, oleic; only 300 mg in a capsule) and 7- (b-hydroxyethyl) -theophylline (50 mg in a capsule), as well as in intravenous ampoules injections with the content of the same acids in the amount of 500 mg, pyridoxine hydrochloride 4 mg, nicotinic acid 2 mg; adenosine 5-monophosphate (AMP) 2 mg.
The lipid-lowering effect of the drug is due to the action of unsaturated fatty acids (see Linetol) and other components. The presence of a theophylline derivative in the capsules may contribute to the antiaggregatory effect, and the content of nicotinic acid and other components in the amullah has a lipid-lowering effect, although the dose of nicotinic acid in the preparation (2 mg in the ampoule) is small.
Recommended for use with hypercholesterolemia and hypertriglyceridemia, atherosclerosis, disorders of the coronary, cerebral and peripheral circulation, nephrotic syndrome and other diseases associated with hyperlipoproteinemia.
Assign inside adults 2 capsules (do not chew) 3 times a day before meals (with a small amount of water). The course of treatment is 1 - 6 months or more.
Injected into the vein (slowly) by 10-20 ml (10 ml in an ampoule) for 2-4 weeks, then transferred to maintenance therapy (1-2 capsules orally 3 times a day).
The drug is usually well tolerated. Intravenous administered without additional dilution. Dilution with sodium chloride solutions is not allowed. Intramuscular injections are painful.
Forms of release: in capsules in packing on 50 pieces; in 10 ml ampoules in a package of 5 ampoules.
Storage: in a cool dry (capsule) place.